Arhaus, Inc. (ARHS)

NASDAQConsumer DiscretionarySpecialty RetailSnapshot 2026-10-23

$11.70+1.47%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Arhaus, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+0.6%

+10% or more+5%0%−5%−10% or less

0.57 → 0.58 EPS · FY ending Dec 31, 2027 · 12 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 11 to 12; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q3
Revenue	$355M–$375M	—
EBITDA	$26M–$34Mnon-GAAP	—
Revenue growth	3%–8.8%	—
FY 2026 · Q4
Revenue	—	392.86M
EPS	—	0.155
FY 2026 · Annual
Revenue	$1.43B–$1.47B	1.46B
EPS	—	0.536
EBITDA	$160M–$171Mnon-GAAP	—
Revenue growth	3.7%–6.6%	—
FY 2027 · Annual
Revenue	—	1.56B
EPS	—	0.576

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Improve adjusted EBITDA through cost control	A supporting condition in Arhaus, Inc.'s published investment case. The stated target is Maintain or improve adjusted EBITDA margin.	Improving	Adjusted EBITDA margin declines meaningfully next year	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 of last 2 quarters. Adjusted EBITDA increased 16.8% to $70 million in 2026-Q2 but decreased 3.1% to $18 million in 2026-Q1. Management's focus on disciplined execution and operational efficiency is reflected in the strong Q2 improvement, indicating partial delivery with some variability. Delivery assessment Oct 24, 2026
Keep capital spending within $70M-$90M in FY26	A supporting condition in Arhaus, Inc.'s published investment case. The stated target is $70M to $90M.	Intact	Capital spending exceeds $90M or falls below $70M in FY26	Capital expenditures: $21.213M FY2026-Q2; GAAP. Published target: $70M to $90M. Target period is not explicitly aligned with this observation. Source published Aug 6, 202621,213,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 of last 2 quarters. Company-funded capital expenditures were $13 million in 2026-Q1 and $29 million in 2026-Q2, totaling $42 million in the first half of 2026. The full-year guidance remains $70 million to $90 million, indicating management is managing capex within planned ranges and delivering on this priority. Delivery assessment Oct 24, 2026
Sustain revenue growth to about $1.45B in FY26	A primary condition in Arhaus, Inc.'s published investment case. The stated target is ~$1.45B.	Under Pressure	Revenue falls below $1.43B in FY26	Revenue: $384.897M FY2026-Q2; GAAP. Published target: ~$1.45B. Target period is not explicitly aligned with this observation. Source published Aug 6, 2026384,897,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 4d36975d-dd95-41b5-a44c-7d5c98916396. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 of last 2 quarters. Net revenue grew from $314 million in 2026-Q1 to $385 million in 2026-Q2, representing year-over-year increases of 0.9% and 7.4% respectively. Management's emphasis on revenue growth aligns with these improving results, indicating delivery on this priority. Delivery assessment Oct 24, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$0.58

$0.55 → $0.58 · observed estimates

FY2027 revenue$1.56B

$1.54B → $1.56B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$0.55	$1,537,864,500	14 / 13
2026-07-25	$0.55	$1,538,356,810	14 / 13
2026-07-26	$0.55	$1,538,356,810	14 / 13
2026-07-27	$0.55	$1,538,364,500	14 / 13
2026-07-28	$0.55	$1,538,364,500	14 / 13
2026-07-29	$0.55	$1,538,364,500	14 / 13
2026-07-30	$0.55	$1,538,364,500	14 / 13
2026-07-31	$0.55	$1,538,364,500	14 / 13
2026-08-01	$0.55	$1,538,364,500	14 / 13
2026-08-02	$0.55	$1,538,364,500	14 / 13
2026-08-03	$0.55	$1,538,364,500	14 / 13
2026-08-04	$0.55	$1,538,364,500	14 / 13
2026-08-05	$0.55	$1,538,607,820	14 / 13
2026-08-06	$0.55	$1,538,607,820	14 / 13
2026-08-07	$0.55	$1,538,598,861	11 / 10
2026-08-08	$0.57	$1,547,192,040	12 / 13
2026-08-09	$0.57	$1,547,192,040	12 / 13
2026-08-10	$0.57	$1,547,192,040	12 / 13
2026-08-11	$0.57	$1,552,768,960	14 / 13
2026-08-12	$0.57	$1,552,768,960	14 / 13
2026-08-13	$0.57	$1,552,768,960	14 / 13
2026-08-14	$0.55	$1,538,598,861	11 / 10
2026-08-15	$0.55	$1,538,598,861	11 / 10
2026-08-16	$0.55	$1,538,598,861	11 / 10
2026-08-17	$0.55	$1,538,598,861	11 / 10
2026-08-18	$0.55	$1,538,598,861	11 / 10
2026-08-19	$0.55	$1,538,598,861	11 / 10
2026-08-20	$0.56	$1,551,003,184	11 / 10
2026-08-21	$0.56	$1,551,003,184	11 / 10
2026-08-22	$0.56	$1,551,003,184	11 / 10
2026-08-23	$0.56	$1,551,003,184	11 / 10
2026-08-24	$0.56	$1,551,003,184	11 / 10
2026-08-25	$0.56	$1,551,003,184	11 / 11
2026-08-26	$0.56	$1,551,667,242	11 / 11
2026-08-27	$0.56	$1,551,667,242	11 / 11
2026-08-28	$0.56	$1,551,667,242	11 / 11
2026-08-29	$0.56	$1,551,667,242	11 / 11
2026-08-30	$0.56	$1,551,667,242	11 / 11
2026-08-31	$0.56	$1,551,667,242	11 / 11
2026-09-01	$0.56	$1,551,667,242	11 / 11
2026-09-02	$0.57	$1,551,667,242	11 / 11
2026-09-03	$0.57	$1,551,667,242	11 / 11
2026-09-04	$0.57	$1,551,667,242	11 / 11
2026-09-05	$0.57	$1,551,667,242	11 / 11
2026-09-06	$0.57	$1,551,667,242	11 / 11
2026-09-07	$0.57	$1,551,667,242	11 / 11
2026-09-08	$0.57	$1,551,667,242	11 / 11
2026-09-09	$0.57	$1,551,667,242	11 / 11
2026-09-10	$0.57	$1,551,667,242	11 / 11
2026-09-11	$0.57	$1,551,667,242	11 / 11
2026-09-12	$0.57	$1,551,667,242	11 / 11
2026-09-13	$0.57	$1,551,667,242	11 / 11
2026-09-14	$0.57	$1,551,667,242	11 / 11
2026-09-15	$0.57	$1,551,667,242	11 / 11
2026-09-16	$0.57	$1,551,667,242	11 / 11
2026-09-17	$0.57	$1,551,667,242	11 / 11
2026-09-18	$0.57	$1,551,667,242	11 / 11
2026-09-19	$0.57	$1,551,667,242	11 / 11
2026-09-20	$0.57	$1,551,667,242	11 / 11
2026-09-21	$0.57	$1,551,667,242	11 / 11
2026-09-22	$0.57	$1,552,624,385	11 / 11
2026-09-23	$0.57	$1,552,624,385	11 / 11
2026-09-24	$0.57	$1,552,624,385	11 / 11
2026-09-25	$0.57	$1,552,624,385	11 / 11
2026-09-26	$0.57	$1,552,624,385	11 / 11
2026-09-27	$0.57	$1,552,624,385	11 / 11
2026-09-28	$0.57	$1,552,624,385	11 / 11
2026-09-29	$0.57	$1,552,624,385	11 / 11
2026-09-30	$0.57	$1,552,624,385	11 / 11
2026-10-01	$0.57	$1,552,624,385	11 / 11
2026-10-02	$0.57	$1,552,623,830	11 / 11
2026-10-03	$0.57	$1,552,623,830	11 / 11
2026-10-04	$0.57	$1,552,623,830	11 / 11
2026-10-05	$0.57	$1,552,623,830	11 / 11
2026-10-06	$0.57	$1,552,623,830	11 / 11
2026-10-07	$0.57	$1,553,788,671	11 / 11
2026-10-08	$0.57	$1,553,788,671	12 / 11
2026-10-09	$0.57	$1,553,788,671	12 / 11
2026-10-10	$0.57	$1,553,788,671	12 / 11
2026-10-11	$0.57	$1,553,788,671	12 / 11
2026-10-12	$0.57	$1,553,788,671	12 / 11
2026-10-13	$0.57	$1,553,788,671	12 / 11
2026-10-14	$0.57	$1,553,787,784	12 / 11
2026-10-15	$0.57	$1,553,787,784	12 / 11
2026-10-16	$0.57	$1,553,787,784	12 / 11
2026-10-17	$0.57	$1,553,787,784	12 / 11
2026-10-18	$0.57	$1,554,859,213	12 / 11
2026-10-19	$0.57	$1,554,859,213	12 / 11
2026-10-20	$0.57	$1,554,859,213	12 / 11
2026-10-21	$0.58	$1,557,307,312	12 / 11
2026-10-22	$0.58	$1,557,307,312	12 / 11
2026-10-23	$0.58	$1,557,307,312	12 / 11
2026-10-24	$0.58	$1,557,307,312	12 / 11

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	5	10
2026-06-01	5	10
2026-07-01	5	10
2026-08-01	6	10
2026-09-01	7	9
2026-10-01	8	8

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 8 Buy / Strong Buy · 8 Hold · 0 Sell / Strong Sell

1 upgrades0 downgrades1 maintains

Recent actions · Sep 25–Oct 24 · 2 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Piper SandlerOct 20 · prior May 11

$8.00 → $13.00+62.5%

$0$7.15$14.30

1 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Improve adjusted EBITDA through cost controlDirect metric needs a verified mapping
Keep capital spending within $70M-$90M in FY26Capital expenditures: $21.213M
Sustain revenue growth to about $1.45B in FY26Published status: Under Pressure

Next proof point

Nov 5, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

2.0%Typical daily move · historical

Downside history

-49.2%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Arhaus, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

ARHS is a growth-oriented consumer discretionary business with recent financial performance in the stronger half of its industry. Its long-term thesis is intact, but this is not a low-risk setup: management and earnings quality are rated neutral, while overall risk is elevated.

What's priced into Arhaus, Inc.

The valuation is expensive versus peers, with a 1.76 premium, though confidence in that estimate is low. The expectations gap is moderate, and the evidence points to valuation as the main source of fragility rather than a combination of weak results and turbulence.

What the fundamentals likely do

Near term, recent results show improving revenue growth, from 0.9% year-over-year in the first quarter to 7.4% in the second quarter. Adjusted EBITDA rose 16.8% in the second quarter after falling 3.1% in the first, so improvement is real but uneven; capital spending remains within management’s stated annual range. The next guidance update is a key risk, with smaller company size and a downward trend in earnings surprises adding caution despite a low estimated miss probability.

What Arhaus, Inc. hinges on

Over the next few quarters, the thesis depends on maintaining revenue growth, improving adjusted EBITDA with less variation, and keeping capital spending within plan. A guidance cut would weaken the near-term case. Results and guidance from consumer discretionary leaders such as AMZN, BABA, and PDD could also strengthen or reduce the sector tailwind.